Form 10-Q · Quarterly report
Linde plc 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0001707925
- Accession no.
- 0001628280-26-068079
Summary
Linde plc's third-quarter 2026 sales rose 9% year over year to $9.404 billion and nine-month sales rose 9% to $27.474 billion, driven by price/mix, volume, currency, acquisitions, and cost pass-through. Reported third-quarter operating profit fell 9% due to $425 million in cost reduction program and other charges, while adjusted operating profit and adjusted diluted EPS rose 8% and 9%, respectively.
Key points
- Third-quarter 2026 sales increased 9% to $9.404 billion, with volume up 2% and price/mix up 3%.
- Reported third-quarter operating profit decreased 9% to $2.150 billion, while adjusted operating profit increased 8%.
- Third-quarter net income attributable to Linde plc fell 12%, but adjusted diluted EPS increased 9%.
- Linde recorded $425 million in third-quarter cost reduction program and other charges, including $200 million of severance and $183 million of non-cash charges primarily related to the U.S. homecare business; headcount was 64,512, down 977 from a year earlier.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Results of Operations Below is a discussion of the results of operations for the third quarter of 2026 and for the nine months ended September 30, 2026 compared to the respective 2025 periods. Sales Quarter Ended September 30, 2026 vs. 2025 Nine months ended September 30, 2026 vs. 2025 % Change % Change Factors Contributing to Changes - Sales Volume 2 % 2 % Price/Mix 3 % 3 % Cost pass-through 1 % 1 % Currency 1 % 2 % Acquisitions/divestitures 1 % 1 % Engineering 1 % — % 9 % 9 % Sales increased by 9% both in the third quarter of 2026 and for the nine months ended September 30, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.